OSLO, Norway, May 3, 2023 /PRNewswire/ -- Photocure ASA
(OSE: PHO), held its annual general meeting on 3 May 2023 at 17:00 hours (CET).
The minutes from the general meeting setting out the resolved
resolutions are attached hereto.
For further information, please contact:
Photocure
CFO Erik Dahl
Tel: + 47 450 55 000
Email: ed@photocure.no
About Photocure ASA
Photocure: The Bladder Cancer Company delivers transformative
solutions to improve the lives of bladder cancer patients. Our
unique technology, which makes cancer cells glow bright pink, has
led to better health outcomes for patients worldwide. Photocure is
headquartered in Oslo, Norway, and
listed on the Oslo Stock Exchange (OSE: PHO). For more information,
please visit us at www.photocure.com, www.hexvix.com or
www.cysview.com.
This information is subject to the disclosure requirements
pursuant to section 5 -12 of the Norwegian Securities Trading
Act.
The following files are available for download:
|
https://mb.cision.com/Main/17498/3763249/2031409.pdf
|
Release
|
|
https://mb.cision.com/Public/17498/3763249/ad5d353a218af8b6.pdf
|
Photocure - Minutes
from AGM 2023 ENG
|
|
https://mb.cision.com/Public/17498/3763249/b7bb5ae4416dddbb.pdf
|
Photocure - Minutes
from AGM 2023 NOR
|
View original
content:https://www.prnewswire.co.uk/news-releases/photocure-asa--annual-general-meeting-held-301814940.html